期刊文献+

基于慢性粒细胞白血病(CML)中血管内皮生长因子(VEGF)的高表达探讨大黄蛰虫丸对CML K562细胞VEGF表达的影响 被引量:7

Expression of Vascular Endothelial Growth Factor(VEGF) in Chronic Myelogenous Leukemia(CML) Patients and Influence of Serum Containing Dahuang Zhechong Pills on VEGF Expression in K562 Cells
下载PDF
导出
摘要 【目的】通过观察大黄蛰虫丸对慢性粒细胞白血病(CML)K562细胞血管内皮生长因子(VEGF)表达的影响,探索应用抗血管新生药物治疗CML的新途径。【方法】采用酶联免疫吸附(ELISA)法,检测CML慢性期(38例)、急变期(11例)患者及正常人(9例)血清中VEGF的含量;并用SD大鼠制备大黄蛰虫丸含药血清,用ELISA法检测K562细胞的VEGF含量。【结果】与正常对照组比较,CML慢性期、急变期患者血清VEGF含量显著升高(P<0.05或P<0.01);与正常对照组比较,大黄蛰虫丸含药血清预处理K562细胞的VEGF蛋白分泌量显著下降(P<0.01),而且VEGF表达随着作用药物浓度的增大而递减。【结论】VEGF在CML慢性期、急变期的含量增高,可能与CML的发病、进展及预后有关;大黄蛰虫丸可抑制慢性粒细胞白血病K562细胞VEGF的表达,使蛋白表达量下降,且呈浓度依赖性。 Objective To observe the effect of serum containing Dahuang Zhechong Pills on vascular endothelial growth factor ( VEGF) expression in K562 cells of chronic myelogenous leukemia ( CML) and to develop new antiangiogenic drugs for CML treatment. Methods Enzyme-linked immunosorbent assay ( ELISA) was used for the detection of serum VEGF content in 38 CML patients, 11 acute myelogenous leukemia patients and 9 healthy volunteers. SD rats were used for the preparation of serum containing Dahuang Zhechong Pills, and then ELISA was applied for the detection of VEGF content in K562 cells pretreated with serum containing Dahuang Zhechong Pills. Results Compared with the healthy volunteers, myelogenous leukemia patients at chronic phase and acute phase had high serum VEGF content ( P〈0.05 or P〈0.01) . Compared with blank serum control group, the secretion of VEGF in K562 cells pretreated with serum containing Dahuang Zhechong Pills was decreased obviously ( P〈0.01) , and VEGF expression decreased with the increase of drug concentration. Conclusion VEGF content is increased in myelogenous leukemia patients at chronic phase and acute phase, which may be related to the pathogenesis, progress and prognosis of chronic myelogenous leukemia. Serum containing Dahuang Zhechong Pills can inhibit the expression of VEGF in chronic myelogenous leukemia K562 cells and decrease VEGF protein expression in concentration-dependent manner.
出处 《广州中医药大学学报》 CAS 2015年第1期44-47,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 国家自然科学基金面上项目资助(编号:81273987) 山东省自然科学基金青年项目资助(编号:ZR2011HQ050)
关键词 慢性粒细胞性白血病/中药疗法 大黄蛰虫丸/治疗应用 血管内皮生长因子 K562细胞 Chronic myeloid leukemia/TCD therapy Dahuang Zhechong Pills/therapeutic use Vascular endothelial growth factor K562 cells
  • 相关文献

参考文献10

  • 1Fragoso R, Elias A P, Dias S. Autocrine VEGF loops, signaling pathways, and acute leukemia regulation[J]. Leuk Lymphoma, 2007, 48 (3): 481.
  • 2Kurosu T, Ohga N, Hida Y, et al. HuR keeps an angiogenic switch on by stabilizing mRNA of VEGF and COX-2 in tumour endothelium[J]. Br J Cancer, 2011, 104 (5): 819.
  • 3Negaard H F, Iversen N, Bowitz Lothe I M, et al. Increased bone marrow microvascular density in hematological malignancies is associated with differential regulation of angiogcnic factors[J]. Leukemia, 2009, 23 (1): 162.
  • 4李树军,石太新,唐成和.急性白血病患儿骨髓细胞血管内皮生长因子及其受体表达[J].实用儿科临床杂志,2007,22(15):1154-1155. 被引量:5
  • 5Verstovsek S, Lunsin S, Kantarjian H, et al. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia[J]. Leukemia Research, 2003, 27 (7): 571.
  • 6Podar K, Anderson K C. The pathophysiologic role of VEGF in hematologic malignancies : therapeutic implications [ J ]. Blood, 2005, 105 (4): 1383.
  • 7Hicklin D J, Ellis L M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis[J]. J Clin Oncol, 2005, 23 (5): 1011.
  • 8吴顺杰,颜美心,张惠臣,徐培平.活血化瘀法治疗慢性粒细胞性白血病临证浅识[J].中医药学刊,2001,19(4):343-344. 被引量:6
  • 9郑瑾,刘强,王宗仁,李军昌,王文,马爱玲,马静,李晶华,肖铁卉.活血化瘀中药复方诱导K562细胞凋亡[J].第四军医大学学报,2003,24(5):427-429. 被引量:19
  • 10许子亮,韩中朝.VEGF与血液学恶性疾病[J].国际病理科学与临床杂志,2006,26(4):318-320. 被引量:8

二级参考文献40

共引文献32

同被引文献98

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部